Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients

Thierry Prazuck, Raphael Serreau, Aurelie Theillay, Sandra Pallay, Daniela Pires-Roteia, Fanny Prazuck, Fabien Lesne
doi: https://doi.org/10.1101/2022.09.29.22280448

Article Information

doi 
https://doi.org/10.1101/2022.09.29.22280448
History 
  • September 30, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Thierry Prazuck1,*,
  2. Raphael Serreau2,
  3. Aurelie Theillay1,
  4. Sandra Pallay1,
  5. Daniela Pires-Roteia1,
  6. Fanny Prazuck1 and
  7. Fabien Lesne3
  1. 1Service des maladies infectieuses, CHR Orleans, France
  2. 2PsycoMADD, CHU Paul Brousse, APHP, Univeristé Paris Saclay
  3. 3Laboratoire de biologie moléculaire, CHR Orleans, France
  1. ↵*(corresponding author) thierry.prazuck{at}chr-orleans.fr
Back to top
Posted September 30, 2022.
Download PDF
Data/Code
Email
Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients
Thierry Prazuck, Raphael Serreau, Aurelie Theillay, Sandra Pallay, Daniela Pires-Roteia, Fanny Prazuck, Fabien Lesne
medRxiv 2022.09.29.22280448; doi: https://doi.org/10.1101/2022.09.29.22280448
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area